TITLE:
Study Evaluating rhIL-11 in Left-Sided Ulcerative Colitis

CONDITION:
Ulcerative Colitis

INTERVENTION:
rhIL-11

SUMMARY:

      To explore the safety of orally delivered rhIL-11 in patients with mild to moderate
      left-sided ulcerative colitis.

      To explore the effects of orally administered rhIL-11 on pharmacogenomics in blood samples
      and in colonic biopsy tissue samples.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Documented, signed informed consent to participate in this study

          -  Age greater than or equal to 18 years

          -  Documented diagnosis of ulcerative colitis by standard clinical criteria, including
             endoscopy (either flexible sigmoidoscopy or colonoscopy, sufficient to define the
             proximal limit of disease) with biopsy

        Exclusion Criteria:

          -  Crohn's disease

          -  Ulcerative proctitis

          -  Ulcerative colitis extending beyond the splenic flexure
      
